MRP ₹35.5
(Inclusive of all Taxes)
₹5.3 Cashback (15%)
Extra 15% Off with Bank Offers
Secure Payment
India's Most Trusted Pharmacy
Genuine Products
Have a query?
Drug-Drug Interactions
Critical
Critical
Drug-Drug Interactions
Login/Sign Up
Critical
How does the drug interact with Meftal-P Dispersible Tablet:
Co-administration of Meftal-P Dispersible Tablet with Meloxicam together can increase the risk or severity of bleeding.
How to manage the interaction:
Taking Meftal-P Dispersible Tablet with Meloxicam together is generally avoided as it can result in an interaction, it can be taken if a doctor has advised it. However, if you notice any unusual bleeding or bruising, other signs of bleeding, dizziness, lightheadedness, red or black tarry stools, coughing up or vomiting blood, severe headache, and weakness, you should contact a doctor immediately. Do not stop using any medications without talking a doctor.
Co-administration of Meftal-P Dispersible Tablet with Meloxicam together can increase the risk or severity of bleeding.
How to manage the interaction:
Taking Meftal-P Dispersible Tablet with Meloxicam together is generally avoided as it can result in an interaction, it can be taken if a doctor has advised it. However, if you notice any unusual bleeding or bruising, other signs of bleeding, dizziness, lightheadedness, red or black tarry stools, coughing up or vomiting blood, severe headache, and weakness, you should contact a doctor immediately. Do not stop using any medications without talking a doctor.
Critical
How does the drug interact with Meftal-P Dispersible Tablet:
Coadministration of Meftal-P Dispersible Tablet with Ketorolac can increase the risk or severity of gastric bleeding and ulcers.
How to manage the interaction:
Taking Meftal-P Dispersible Tablet with Ketorolac together can result in an interaction, it can be taken if your doctor has advised it. However, if you notice any unusual bleeding or bruising, other signs of bleeding, dizziness, lightheadedness, red or black tarry stools, coughing up or vomiting blood, severe headache, and weakness, you should contact a doctor immediately. Do not stop using any medications without talking to a doctor.
Coadministration of Meftal-P Dispersible Tablet with Ketorolac can increase the risk or severity of gastric bleeding and ulcers.
How to manage the interaction:
Taking Meftal-P Dispersible Tablet with Ketorolac together can result in an interaction, it can be taken if your doctor has advised it. However, if you notice any unusual bleeding or bruising, other signs of bleeding, dizziness, lightheadedness, red or black tarry stools, coughing up or vomiting blood, severe headache, and weakness, you should contact a doctor immediately. Do not stop using any medications without talking to a doctor.
Severe
How does the drug interact with Meftal-P Dispersible Tablet:
Meftal-P Dispersible Tablet and Apixaban co-administration may raise the risk of bleeding.
How to manage the interaction:
Even though combining Meftal-P Dispersible Tablet and Apixaban may cause an interaction, it is still possible to take it if your doctor advises you to. Consult a doctor if you experience symptoms like blood in your urine or stool (or a black stool), severe bruising, prolonged nosebleeds, feeling dizzy or lightheaded, weakness or severe headache, vomiting blood or coughing up blood, heavy menstrual bleeding (in women), difficulty breathing, or chest pain. Without first consulting your doctor, never stop taking any medications.
Meftal-P Dispersible Tablet and Apixaban co-administration may raise the risk of bleeding.
How to manage the interaction:
Even though combining Meftal-P Dispersible Tablet and Apixaban may cause an interaction, it is still possible to take it if your doctor advises you to. Consult a doctor if you experience symptoms like blood in your urine or stool (or a black stool), severe bruising, prolonged nosebleeds, feeling dizzy or lightheaded, weakness or severe headache, vomiting blood or coughing up blood, heavy menstrual bleeding (in women), difficulty breathing, or chest pain. Without first consulting your doctor, never stop taking any medications.
Severe
How does the drug interact with Meftal-P Dispersible Tablet:
Coadministration of Meftal-P Dispersible Tablet with Etodolac can increase the risk or severity of gastric bleeding, ulceration, and rarely, perforation leading to serious blood loss.
How to manage the interaction:
Taking Meftal-P Dispersible Tablet with Etodolac together can result in an interaction, it can be taken if a doctor has advised it. However, if you notice any unusual bleeding or bruising, dizziness, lightheadedness, red or black tarry stools, coughing up or vomiting blood, severe headache, and weakness, you should contact the doctor immediately. Do not stop using any medications without talking to a doctor.
Coadministration of Meftal-P Dispersible Tablet with Etodolac can increase the risk or severity of gastric bleeding, ulceration, and rarely, perforation leading to serious blood loss.
How to manage the interaction:
Taking Meftal-P Dispersible Tablet with Etodolac together can result in an interaction, it can be taken if a doctor has advised it. However, if you notice any unusual bleeding or bruising, dizziness, lightheadedness, red or black tarry stools, coughing up or vomiting blood, severe headache, and weakness, you should contact the doctor immediately. Do not stop using any medications without talking to a doctor.
How does the drug interact with Meftal-P Dispersible Tablet:
Taking Human immunoglobulin with Meftal-P Dispersible Tablet, may raise the risk of kidney problems.
How to manage the interaction:
There may be a possibility of interaction between Human immunoglobulin and Meftal-P Dispersible Tablet, but it can be taken if prescribed by a doctor. However, if you experience nausea, vomiting, loss of appetite, increased or decreased urination, sudden weight gain or loss, fluid retention, swelling, shortness of breath, muscle cramps, tiredness, weakness, dizziness, confusion, or an irregular heart rhythm, consult a doctor. Do not discontinue any medications without consulting a doctor.
Taking Human immunoglobulin with Meftal-P Dispersible Tablet, may raise the risk of kidney problems.
How to manage the interaction:
There may be a possibility of interaction between Human immunoglobulin and Meftal-P Dispersible Tablet, but it can be taken if prescribed by a doctor. However, if you experience nausea, vomiting, loss of appetite, increased or decreased urination, sudden weight gain or loss, fluid retention, swelling, shortness of breath, muscle cramps, tiredness, weakness, dizziness, confusion, or an irregular heart rhythm, consult a doctor. Do not discontinue any medications without consulting a doctor.
Mefenamic acidEdoxaban
Severe
How does the drug interact with Meftal-P Dispersible Tablet:
Using Edoxaban together with Meftal-P Dispersible Tablet may increase the risk of bleeding and hemorrhage.
How to manage the interaction:
Although taking Meftal-P Dispersible Tablet and Edoxaban together can cause an interaction, it can be taken if your doctor has suggested it. If you notice any of these signs, it's important to contact a doctor right away - problems with bleeding, dizziness, black or tarry stools, severe headache, weakness, or vomiting. Do not stop using any medications without talking to a doctor.
Using Edoxaban together with Meftal-P Dispersible Tablet may increase the risk of bleeding and hemorrhage.
How to manage the interaction:
Although taking Meftal-P Dispersible Tablet and Edoxaban together can cause an interaction, it can be taken if your doctor has suggested it. If you notice any of these signs, it's important to contact a doctor right away - problems with bleeding, dizziness, black or tarry stools, severe headache, weakness, or vomiting. Do not stop using any medications without talking to a doctor.
Severe
How does the drug interact with Meftal-P Dispersible Tablet:
Co-administration of Meftal-P Dispersible Tablet with Prasugrel can increase the risk or severity of gastric bleeding, ulceration, and rarely, perforation leading to serious blood loss.
How to manage the interaction:
Taking Meftal-P Dispersible Tablet with Prasugrel together can result in an interaction, it can be taken if your doctor has advised it. However, if you notice any unusual bleeding or bruising, other signs of bleeding, dizziness, lightheadedness, red or black tarry stools, coughing up or vomiting blood, severe headache, and weakness, you should contact a doctor immediately. Do not stop using any medications without talking to a doctor.
Co-administration of Meftal-P Dispersible Tablet with Prasugrel can increase the risk or severity of gastric bleeding, ulceration, and rarely, perforation leading to serious blood loss.
How to manage the interaction:
Taking Meftal-P Dispersible Tablet with Prasugrel together can result in an interaction, it can be taken if your doctor has advised it. However, if you notice any unusual bleeding or bruising, other signs of bleeding, dizziness, lightheadedness, red or black tarry stools, coughing up or vomiting blood, severe headache, and weakness, you should contact a doctor immediately. Do not stop using any medications without talking to a doctor.
How does the drug interact with Meftal-P Dispersible Tablet:
Using Meftal-P Dispersible Tablet and baricitinib together may increase the risk of gastrointestinal perforation (a serious health condition where a hole develops through the stomach or intestine).
How to manage the interaction:
Co-administration of Meftal-P Dispersible Tablet with Baricitinib can result in an interaction, but it can be taken if your doctor has advised it. If you notice any signs like severe stomach pain, fever, or vomiting, consult a doctor. Do not stop using any medications without talking to a doctor.
Using Meftal-P Dispersible Tablet and baricitinib together may increase the risk of gastrointestinal perforation (a serious health condition where a hole develops through the stomach or intestine).
How to manage the interaction:
Co-administration of Meftal-P Dispersible Tablet with Baricitinib can result in an interaction, but it can be taken if your doctor has advised it. If you notice any signs like severe stomach pain, fever, or vomiting, consult a doctor. Do not stop using any medications without talking to a doctor.
Severe
How does the drug interact with Meftal-P Dispersible Tablet:
Coadministration of cidofovir with Meftal-P Dispersible Tablet can increase the risk of kidney problems.
How to manage the interaction:
Although taking Meftal-P Dispersible Tablet and cidofovir together can cause an interaction, it can be taken if your doctor has suggested it. However, if you experience nausea, vomiting, loss of appetite, increased or decreased urination, sudden weight gain or loss, fluid retention, swelling, shortness of breath, muscle cramps, tiredness, weakness, dizziness, confusion, or an irregular heart rhythm, consult a doctor. Do not discontinue any medications without consulting a doctor.
Coadministration of cidofovir with Meftal-P Dispersible Tablet can increase the risk of kidney problems.
How to manage the interaction:
Although taking Meftal-P Dispersible Tablet and cidofovir together can cause an interaction, it can be taken if your doctor has suggested it. However, if you experience nausea, vomiting, loss of appetite, increased or decreased urination, sudden weight gain or loss, fluid retention, swelling, shortness of breath, muscle cramps, tiredness, weakness, dizziness, confusion, or an irregular heart rhythm, consult a doctor. Do not discontinue any medications without consulting a doctor.
How does the drug interact with Meftal-P Dispersible Tablet:
The combined use of Meftal-P Dispersible Tablet and Tenofovir alafenamide can increase the risk of kidney problems.
How to manage the interaction:
Taking Meftal-P Dispersible Tablet and Tenofovir alafenamide together can lead to an interaction, it can be taken if advised by your doctor. However, if you experience any symptoms like nausea, vomiting, loss of appetite, increased or decreased urination, sudden weight gain or weight loss, fluid retention, swelling, shortness of breath, bone pain, muscle cramps, tiredness, weakness, dizziness, confusion, and irregular heart rhythm, contact a doctor immediately. Do not discontinue any medications without consulting a doctor.
The combined use of Meftal-P Dispersible Tablet and Tenofovir alafenamide can increase the risk of kidney problems.
How to manage the interaction:
Taking Meftal-P Dispersible Tablet and Tenofovir alafenamide together can lead to an interaction, it can be taken if advised by your doctor. However, if you experience any symptoms like nausea, vomiting, loss of appetite, increased or decreased urination, sudden weight gain or weight loss, fluid retention, swelling, shortness of breath, bone pain, muscle cramps, tiredness, weakness, dizziness, confusion, and irregular heart rhythm, contact a doctor immediately. Do not discontinue any medications without consulting a doctor.
Drug-Food Interactions
No Drug - Food interactions found in our database. Some may be unknown. Consult your doctor for what to avoid during medication.
Drug-Food Interactions
Login/Sign Up
All Substitutes & Brand Comparisons
RX
Out of StockMeff-P 100mg Tablet
Bestochem Formulations (I) Ltd
₹10
(₹0.9 per unit)
71% CHEAPERRX
Ibuclin P Tablet 10's
Dr Reddy's Laboratories Ltd
₹10.5
(₹0.95 per unit)
70% CHEAPERRX
Out of StockRaymef 100mg Tablet DT
₹11
(₹0.99 per unit)
69% CHEAPER
Disclaimer
While we strive to provide complete, accurate, and expert-reviewed content on our 'Platform', we make no warranties or representations and disclaim all responsibility and liability for the completeness, accuracy, or reliability of the aforementioned content. The content on our platform is for informative purposes only, and may not cover all clinical/non-clinical aspects. Reliance on any information and subsequent action or inaction is solely at the user's risk, and we do not assume any responsibility for the same. The content on the Platform should not be considered or used as a substitute for professional and qualified medical advice. Please consult your doctor for any query pertaining to medicines, tests and/or diseases, as we support, and do not replace the doctor-patient relationship.
Author Details
